Effects of treatment with U-74006F on neurological outcome following experimental spinal cord injury
Douglas K. Anderson, Eugene D. Means(University of Cincinnati Medical Center), J. Mark Braughler, Thomas Waters, Edward D. Hall(Harding University Main Campus), John M. McCall(ReveraGen BioPharma (United States))
Cited by 164
Related Papers
A multicenter trial on the efficacy of using tirilazad mesylate in cases of head injury
|Journal of neurosurgery|1998|342
Therapeutic Potential of the Lazaroids (21-Aminosteroids) in Acute Central Nervous System Trauma, Ischemia and Subarachnoid Hemorrhage
|Advances in pharmacology|1994|215
Lipid Hydrolysis and Peroxidation in Injured Spinal Cord: Partial Protection with Methylprednisolone or Vitamin E and Selenium
|Central Nervous System Trauma|1985|212
Effect of methylprednisolone in compression trauma to the feline spinal cord
|Journal of neurosurgery|1981|198